We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

227 hedge funds and large institutions have $4.25B invested in Amicus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 74 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

924% more call options, than puts

Call options by funds: $43.4M | Put options by funds: $4.23M

153% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 17

60% more capital invested

Capital invested by funds: $2.66B → $4.25B (+$1.59B)

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

12% more funds holding

Funds holding: 203 → 227 (+24)

0% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 74

2.41% less ownership

Funds ownership: 111.82% → 109.41% (-2.4%)

Holders
227
Holders Change
+24
Holders Change %
+11.82%
% of All Funds
4.65%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
43
Increased
74
Reduced
74
Closed
17
Calls
$43.4M
Puts
$4.23M
Net Calls
+$39.1M
Net Calls Change
+$30M

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$26.1M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$25.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$24.9M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$18.1M
5
JP Morgan Chase
JP Morgan Chase
New York
+$16.8M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$54.9M
2
Morgan Stanley
Morgan Stanley
New York
-$49.1M
3
DM
Deerfield Management
New York
-$22.4M
4
AG
Artal Group
Luxembourg
-$18.3M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$14.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
101
AQR Capital Management
Connecticut
$2.09M -$78.4K -6,431 -4%
QI
102
QS Investors
New York
$1.99M – – –
CAM
103
ClariVest Asset Management
California
$1.93M +$363K +29,808 +30%
SCM
104
Soleus Capital Management
Connecticut
$1.92M +$674K +55,300 +77%
Macquarie Group
105
Macquarie Group
Australia
$1.89M -$286K -23,448 -16%
AWM
106
Affinity Wealth Management
Delaware
$1.78M +$1.5M +123,183 New
MIM
107
MetLife Investment Management
New Jersey
$1.7M – – –
State Board of Administration of Florida Retirement System
108
State Board of Administration of Florida Retirement System
Florida
$1.55M – – –
PVI
109
Pura Vida Investments
New York
$1.54M +$1.25M +102,300 New
Carson Wealth (CWM LLC)
110
Carson Wealth (CWM LLC)
Nebraska
$1.5M – – –
IBT
111
International Biotechnology Trust
United Kingdom
$1.47M – – –
RJA
112
Raymond James & Associates
Florida
$1.47M +$86.9K +7,130 +8%
Principal Financial Group
113
Principal Financial Group
Iowa
$1.47M +$309K +25,355 +35%
Voloridge Investment Management
114
Voloridge Investment Management
Florida
$1.43M +$30.8K +2,530 +3%
Simplex Trading
115
Simplex Trading
Illinois
$1.33M +$801K +65,695 +294%
AC
116
Athanor Capital
New York
$1.32M +$1.07M +87,466 New
Rafferty Asset Management
117
Rafferty Asset Management
New York
$1.32M +$630K +51,694 +145%
SFI
118
Susquehanna Fundamental Investments
Pennsylvania
$1.24M +$1M +82,200 New
MLICM
119
Metropolitan Life Insurance Company (MetLife)
New York
$1.19M +$22.3K +1,831 +2%
AG
120
Algert Global
California
$1.16M -$263K -21,597 -22%
Bank of Montreal
121
Bank of Montreal
Ontario, Canada
$1.15M +$872K +71,575 +9,443%
ProShare Advisors
122
ProShare Advisors
Maryland
$1.14M +$313K +25,671 +51%
CSS
123
Cubist Systematic Strategies
Connecticut
$1.03M +$556K +45,622 +202%
NAM
124
Nexpoint Asset Management
Texas
$991K – – –
QIM
125
Quantitative Investment Management
Virginia
$962K +$778K +63,849 New
3 4
5
6 7

FOLD Hedge Fund Activity: Q2 2020 in Review

227 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q2 2020, worth a combined $4.25B — up 60% from $2.66B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new FOLD positions and 17 closed out — a net gain of 26 holders — while 74 added to existing stakes and 74 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $26.1M. The largest seller was Victory Capital Management, cutting an estimated $54.9M.

  • 227 institutional investors held Amicus Therapeutics (FOLD) as of Q2 2020, up from 203 in Q1 2020.
  • Funds reported $4.25B of Amicus Therapeutics stock for Q2 2020, up 60% quarter-over-quarter.
  • 43 funds opened new Amicus Therapeutics positions in Q2 2020 and 17 closed out, a net change of +26 holders.
  • The largest Amicus Therapeutics buyer in Q2 2020 was Deutsche Bank, an estimated $26.1M added.
  • The largest Amicus Therapeutics seller in Q2 2020 was Victory Capital Management, an estimated $54.9M sold.

Based on aggregated 13F filings for Q2 2020.